
0.5951 BATS BZX Real-Time Price As of 11:30am ET | ![]() Today’s Change | 0.41 Today|||52-Week Range 3.18 | -54.92% Year-to-Date |
The 6 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +656.18% increase from the last price of 0.60.
The current consensus among 7 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.